Source: Fertility and sterility. Conference titles: Scientific Congress and Expo of the American-Society-for-Reproductive-Medicine (ASRM). Unidade: FM
Subjects: ENDOMETRIOSE, HORMÔNIO LIBERADOR DE GONADOTROFINAS, ENDOMÉTRIO, TERAPÊUTICA
ABNT
SURREY, E. et al. Long-term safety and efficacy of elagolix treatment in women with endometriosis associated pain: primary results from two phase 3 extension studies. Fertility and sterility. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://ac.els-cdn.com/S0015028217308142/1-s2.0-S0015028217308142-main.pdf?_tid=befbe701-63d1-4965-8ea4-7c46f2e26dd8&acdnat=1523300337_01f35b643bd672c0351c91e49928397c. Acesso em: 01 jul. 2024. , 2017APA
Surrey, E., Taylor, H. S., Giudice, L. C., Singh, S., Abrão, M. S., Lessey, B. A., et al. (2017). Long-term safety and efficacy of elagolix treatment in women with endometriosis associated pain: primary results from two phase 3 extension studies. Fertility and sterility. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://ac.els-cdn.com/S0015028217308142/1-s2.0-S0015028217308142-main.pdf?_tid=befbe701-63d1-4965-8ea4-7c46f2e26dd8&acdnat=1523300337_01f35b643bd672c0351c91e49928397cNLM
Surrey E, Taylor HS, Giudice LC, Singh S, Abrão MS, Lessey BA, Duan WR, Peloso PM, Schwefel B, Chwakusz K. Long-term safety and efficacy of elagolix treatment in women with endometriosis associated pain: primary results from two phase 3 extension studies [Internet]. Fertility and sterility. 2017 ; 108( 3): E95-E96.[citado 2024 jul. 01 ] Available from: https://ac.els-cdn.com/S0015028217308142/1-s2.0-S0015028217308142-main.pdf?_tid=befbe701-63d1-4965-8ea4-7c46f2e26dd8&acdnat=1523300337_01f35b643bd672c0351c91e49928397cVancouver
Surrey E, Taylor HS, Giudice LC, Singh S, Abrão MS, Lessey BA, Duan WR, Peloso PM, Schwefel B, Chwakusz K. Long-term safety and efficacy of elagolix treatment in women with endometriosis associated pain: primary results from two phase 3 extension studies [Internet]. Fertility and sterility. 2017 ; 108( 3): E95-E96.[citado 2024 jul. 01 ] Available from: https://ac.els-cdn.com/S0015028217308142/1-s2.0-S0015028217308142-main.pdf?_tid=befbe701-63d1-4965-8ea4-7c46f2e26dd8&acdnat=1523300337_01f35b643bd672c0351c91e49928397c